Health & Fitness
Wed, January 25, 2012Tue, January 24, 2012Mon, January 23, 2012Sun, January 22, 2012Sat, January 21, 2012Fri, January 20, 2012Thu, January 19, 2012Wed, January 18, 2012Tue, January 17, 2012Mon, January 16, 2012Fri, January 13, 2012Thu, January 12, 2012Wed, January 11, 2012Bull & Lifshitz, LLP Announces Investigation of Inhibitex, Inc.
Published in Health and Fitness on Thursday, January 19th 2012 at 8:56 GMT by Market Wire
Bull & Lifshitz, LLP Announces Investigation of Inhibitex, Inc. -- NEW YORK, Jan. 19, 2012 /PRNewswire/ --
Bull & Lifshitz, LLP Announces Investigation of Inhibitex, Inc.
NEW YORK, Jan. 19, 2012 /PRNewswire/ -- [ Bull & Lifshitz, LLP ] announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Inhibitex, Inc. (NASDAQ: [ INHX ]) (referred to as "Inhibitex" or the "Company") to Bristol-Myers Squibb Company ("Bristol-Myers Squibb"), in a cash transaction valued at approximately $2.5 billion.
Under the terms of the definitive agreement, Bristol-Myers Squibb will commence a cash tender offer to purchase all of the outstanding shares of Inhibitex's common stock for $26.00 per share. The companies expect the tender offer to close approximately thirty days after commencement of the tender offer. In addition, shareholders with beneficial ownership of approximately 17% of Inhibitex's common stock have entered into agreements with Bristol-Myers Squibb to support the transaction and to tender their shares in the tender offer.
Bull & Lifshitz, LLP's investigation is focused on whether the proposed deal provides adequate value to the Company's shareholders.
If you are a holder of Inhibitex common stock and want to discuss your legal rights, you may [ e-mail ] or call [ Bull & Lifshitz, LLP ] who will, without obligation or cost to you, attempt to answer your questions.
If you are a shareholder of Inhibitex and would like more information about our investigation, please contact [ Joshua M. Lifshitz, Esq. ] by telephone at (866) 313-6222 or by sending an e-mail including your contact information to: [ counsel@nyclasslaw.com ]. All e-mail correspondence should make reference to Inhibitex.
[ Bull & Lifshitz, LLP ] is a New York City-based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions. For more information about the firm, please visit our website at [ www.nyclasslaw.com ].
ATTORNEY ADVERTISING. © 2012 Bull & Lifshitz, LLP. The law firm responsible for this advertisement is Bull & Lifshitz, LLP, 18 East 41st Street, New York, New York 10017, (212) 213-6222. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Bull & Lifshitz, LLP
Phone: 212-213-6222
Fax: 212-213-9405
Email: [ counsel@nyclasslaw.com ]
SOURCE Bull & Lifshitz, LLP
[ Back to top ] RELATED LINKS
[ http://www.nyclasslaw.com ]
